Iberdomide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled, ascending-dose, phase 2a study by Victoria P Werth, Richard A Furie, Ying Ye, Xiaojiang Zhan, Peter H Schafer, Nikolay Delev, Shimon Korish, Michael Weiswasser, Douglas R Hough, Allison Gaudy

Get full text